Eglonyl - Pharmacology:

In contrast to most other neuroleptics which block both dopamine D1 and D2 receptors, Eglonyl is more selective and acts primarily as a dopamine D2 antagonist. Eglonyl appears to lack effects on norepinephrine, acetylcholine, serotonin, histamine, or gamma-aminobutyric acid (GABA) receptors.